Tag: alopecia areata


Pfizer’s Litfulo approved by FDA as first treatment for adolescents with severe alopecia areata

June 26, 2023


Affecting almost seven million people in the US and approximately 147 million people globally, alopecia areata is an autoimmune disease characterised by patchy or complete hair loss on the scalp, face, or body. The condition can develop at any age, […]

FDA, Regulations

FDA approves first systemic treatment for alopecia areata

June 13, 2022

Via: World Pharma News

Today, the U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a disorder that often appears as patchy baldness and affects more than 300,000 people in the U.S. each year. Today’s […]